Andrew Dreyfus - 01 Feb 2024 Form 3 Insider Report for Alto Neuroscience, Inc. (ANRO)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ANRO	Stock Option (Right to Buy)							01 Feb 2024	Common Stock	22,481	$6.23	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	One thirty-sixth (1/36th) of the shares underlying the option vested or shall vest on a monthly basis commencing on the one-month anniversary of October 12, 2023, subject to the Reporting Person's continuous service through such vesting date.